Résultats de la recherche - 6 results
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
protection, infections occurring before 2021 remained associated with significant risk reduction against symptomatic infection. Vaccination and prior infection outperformed vaccination or prior infection ...
Characterization of a Bacteriophage GEC_vB_Bfr_UZM3 Active against.
Infections Bacteriophages Bacteroides fragilis Humans Abstract: is a commensal gut bacterium that is associated with a number of blood and tissue infections. It has not yet been recognized as one of the ...
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
Infections liées aux soins et antibiorésistance Zorginfecties en antibioticaresistentie Healthcare-associated infections and antimicrobial resistance Manuscript versions: DOI: ...
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
observed high vaccine effectiveness (VE) against SARS-CoV2-infection. The replacement of the alpha-‘variant of concern’ (VOC) by the delta- VOC and uncertainty about the time course of immunity called for ...
Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium.
Abstract: The objective of this study was to investigate the incidence and risk factors associated with COVID-19 vaccine breakthrough infections. We included all persons ≥18 years that had been fully ...
Risk factors associated with breakthrough SARS-CoV-2 infections after vaccination: a prospective cohort study in Belgium
Oyen; Chloé Wyndham-Thomas; Lucy Catteau Source: (2022) Health Topics: Doeltreffendheid en veiligheid van vaccins, geneesmiddelen en gezondheidsproducten- Kwaliteit van de medische laboratoria ...